Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Growth Hormone
Refined ghrelin mimetic — stronger GH release than GHRP-6 with less hunger.
Peptide B
Growth Hormone
The most potent GHRP — strong GH release with documented cardioprotective signaling.
Typical vial
5 mg
Typical dose
100 mcg
Half-life
~15-60 minutes
FDA status
Not FDA approved for any indication.
Typical vial
5 mg
Typical dose
100 mcg
Half-life
~55 minutes
FDA status
Not FDA approved for any indication.
GHRP-2 effects
Hexarelin effects
GHRP-2 side effects
Hexarelin side effects
GHRP-2 dosing ranges
GH optimization / anti-aging
100 mcg · Two to three times daily (SubQ) · 8-12 weeks
Combined with CJC-1295 (Mod GRF)
100 mcg of each · Two to three times daily · 8-12 weeks
Adult GHD diagnostic (Japan, clinical)
100 mcg IV bolus · Single dose · One-time test
Hexarelin dosing ranges
Short-course GH stimulation
100 mcg · Two to three times daily (SubQ) · 4 weeks maximum, then 4-week break
Combined with CJC-1295 (Mod GRF)
100 mcg of each · Two to three times daily · 4 weeks on / 4 weeks off
Cardioprotective research
1-2 mcg/kg · Per protocol (research-only) · Variable
GHRP-2: Refined ghrelin mimetic — stronger GH release than GHRP-6 with less hunger. Typical dose 100 mcg. Hexarelin: The most potent GHRP — strong GH release with documented cardioprotective signaling. Typical dose 100 mcg. Both fall under the Growth Hormone category.
Stacking GHRP-2 with Hexarelin is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
GHRP-2 is typically dosed: Two to three times daily (SubQ) for GH optimization / anti-aging; Two to three times daily for Combined with CJC-1295 (Mod GRF); Single dose for Adult GHD diagnostic (Japan, clinical). Hexarelin is typically dosed: Two to three times daily (SubQ) for Short-course GH stimulation; Two to three times daily for Combined with CJC-1295 (Mod GRF); Per protocol (research-only) for Cardioprotective research.
GHRP-2: Not FDA approved for any indication. Hexarelin: Not FDA approved for any indication.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free